INJECTAPAP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Injectapap, and what generic alternatives are available?
Injectapap is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in INJECTAPAP is acetaminophen. There is one drug master file entry for this compound. Ninety-four suppliers are listed for this compound. Additional details are available on the acetaminophen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Injectapap
A generic version of INJECTAPAP was approved as acetaminophen by PERRIGO on February 25th, 2000.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for INJECTAPAP?
- What are the global sales for INJECTAPAP?
- What is Average Wholesale Price for INJECTAPAP?
Summary for INJECTAPAP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 149 |
| Patent Applications: | 4,456 |
| DailyMed Link: | INJECTAPAP at DailyMed |
US Patents and Regulatory Information for INJECTAPAP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Pharm | INJECTAPAP | acetaminophen | INJECTABLE;INJECTION | 017785-001 | Mar 7, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
